Evidence map›Paper›PMID 30113945›Full record

ReviewPain2018

Using stratified medicine to understand, diagnose, and treat neuropathic pain.

Andreas C Themistocleous, Geert Crombez, Georgios Baskozos, David L Bennett

Abstract readReview
In one paragraph

Review in Pain, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. TRPA1 Inhibition Effects by 3-Phenylcoumarin Derivatives.ACS medicinal chemistry letters · 2024
    Article
  6. Article
  7. Article
  8. Central neuropathic pain.Nature reviews. Disease primers · 2023
    Review
  9. Article
  10. Peripheral mechanisms of peripheral neuropathic pain.Frontiers in molecular neuroscience · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. A Role for Global DNA Methylation Level andFrontiers in pain research (Lausanne, Switzerland) · 2021
    Article
  17. Article
  18. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Review
  19. Progress in pain medicine: where are we now?British journal of anaesthesia · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andreas C ThemistocleousThe Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Geert CrombezDepartment of Experimental-Clinical and Health Psychology, Ghent University, Ghent, Belgium.
Georgios BaskozosThe Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
David L BennettThe Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pain ManagementAnimalsBrainElectrophysiologyHumansNeuralgiaPain Measurement

Identifiers

PMID30113945
PMCPMC6130809

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.